“Media studies describe it to be a loophole,” states Alliance for Pharmacy Compounding CEO Scott Brunner. “It’s not a loophole. It’s really intentional coverage.” Brunner has expressed annoyance about how some protection in the rise of compounding GLP-1s conflates unlicensed pharmacies peddling copyright medication or analysis pepti